Amyl Therapeutics
Amyl Therapeutics is a healthcare company, headquartered in Europe.
Entry
2021
Hold
5yr
Status
Active
Est. EV
–
Who owns Amyl Therapeutics?
Amyl Therapeutics is currently owned by Merieux Equity Partners through Mérieux Innovation 1 (2014 vintage), since 2021.
Hand-verified · updated 2026-05-07
Key facts
HQEurope
SectorHealthcare
StatusActive
More from Mérieux Innovation 1
Other portfolio companies in the same fund.
More PE-backed in Healthcare
Comparable healthcare deals from other GPs.
USData refreshed weekly · Sourced from public filings